XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 459,288 $ 1,309
Restricted cash 490 565
Other receivables 262 48
Grants receivable 16 0
Prepaid expenses and other current assets 3,862 144
Total current assets 463,918 2,066
Property, plant, and equipment, net 49,951 45,104
Intangible assets, net 225 258
Total assets 514,094 47,428
Current liabilities    
Accounts payable 1,783 2,700
Accrued expenses 1,135 593
Derivative liability 0 1,239
Stockholder convertible notes payable 0 3,232
Total current liabilities 2,918 7,764
PPP Loan 0 906
Earnout liability 136,199 0
Canadian Government Research and Development Program Liability 6,485 6,197
Redeemable convertible preferred stock warrants 0 19,233
Assumed common stock warrants liability 55,698 0
Stockholder note 5,189 5,189
Related party other liabilities, long-term 5,669 5,517
Other liabilities, long-term 2,984 2,500
Total liabilities 215,142 47,306
Commitments and contingencies (See Note 18)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2021 and December 31, 2020 0 0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 136,754,685 and 70,266,925, issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 13 6
Additional paid-in capital 360,566 98,620
Accumulated deficit (62,035) (98,888)
Accumulated other comprehensive income 408 384
Total stockholders’ equity 298,952 122
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit $ 514,094 $ 47,428